BRCA1 can modulate RNA polymerase II carboxy-terminal domain phosphorylation levels.

A high incidence of breast and ovarian cancers has been linked to mutations in the BRCA1 gene. BRCA1 has been shown to be involved in both positive and negative regulation of gene activity as well as in numerous other processes such as DNA repair and cell cycle regulation. Since modulation ...
of the RNA polymerase II carboxy-terminal domain (CTD) phosphorylation levels could constitute an interface to all these functions, we wanted to directly test the possibility that BRCA1 might regulate the phosphorylation state of the CTD. We have shown that the BRCA1 C-terminal region can negatively modulate phosphorylation levels of the RNA polymerase II CTD by the Cdk-activating kinase (CAK) in vitro. Interestingly, the BRCA1 C-terminal region can directly interact with CAK and inhibit CAK activity by competing with ATP. Finally, we demonstrated that full-length BRCA1 can inhibit CTD phosphorylation when introduced in the BRCA1(-/-) HCC1937 cell line. Our results suggest that BRCA1 could play its ascribed roles, at least in part, by modulating CTD kinase components.
Mesh Terms:
Adenosine Triphosphate, Animals, BRCA1 Protein, Cell Cycle, Cyclin H, Cyclin-Dependent Kinases, Cyclins, Gene Expression Regulation, HeLa Cells, Humans, Phosphorylation, Protein Structure, Tertiary, RNA Polymerase II, Transcription Factor TFIIH, Transcription Factors, TFII
Mol. Cell. Biol.
Date: Aug. 01, 2004
Download Curated Data For This Publication
145768
Switch View:
  • Interactions 9